ClinicalTrials.Veeva

Menu

Testing the Efficiency of Karman Curette in the Treatment of Misoprostol Failure in Women With Missed Abortion

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Abortion, Missed

Treatments

Device: Karman curettage

Study type

Interventional

Funder types

Other

Identifiers

NCT02917785
177-16-MMC

Details and patient eligibility

About

the purpose of this study is to examine the success rates of Karman curettage in completing the abortion after failed recurred treatment with Misoprostol for women with missed abortion.

Enrollment

60 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy women diagnosed with missed abortion treated in Meir Medical Center.
  • The abortion occured during the first trimester of pregnancy.
  • Patients who chose drug therapy (Misoprostol), after retained products of conception were evident on ultrasound.

Exclusion criteria

  • patients with mullarian abnormality (i.e. septal uterus, myoma etc.)
  • patients with significant bleeding
  • Endometrial wall (residua) greater than 20 mm.
  • known or suspected infection
  • known clotting defect
  • women after cesarean section
  • closed cervix

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Karman curettage
Experimental group
Description:
after a retained product of interception is observed in ultrasound examination, the women in this arm will undergo Karman curretage.
Treatment:
Device: Karman curettage
Control
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Meir Pomeranz, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems